跳至主要内容
临床试验/NCT00103155
NCT00103155Unknown1 期

Radiofrequency Ablation for Low Risk Papillary Thyroid Cancer: A Pilot Study

University of California, San Francisco2 个研究点 分布在 1 个国家开始时间: 2004年9月最近更新:
适应症

试验速览

阶段
1 期
试验地点
2
主要终点
Frequency of radiofrequency ablation-associated complications at 2 weeks

研究概览

简要总结

RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Ultrasound-guided radiofrequency ablation may be effective treatment for thyroid cancer.

PURPOSE: This phase I trial is studying the side effects of radiofrequency ablation in treating patients who are undergoing surgery for thyroid cancer.

详细描述

OBJECTIVES:

  • Determine the frequency of complications associated with radiofrequency ablation (RFA) in patients with low-risk papillary thyroid cancer undergoing thyroidectomy.
  • Determine the utility of RFA as a treatment option for these patients.

OUTLINE: This is a pilot study.

An electrosurgical probe is placed by ultrasound guidance into the center of the thyroid tumor. Patients undergo radiofrequency ablation directly to the tumor until the target temperature is reached* for 5 minutes. Patients then undergo standard thyroidectomy.

NOTE: *Takes approximately 15-30 minutes to reach target temperature.

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Frequency of radiofrequency ablation-associated complications at 2 weeks

次要结局

  • Amount of tumor destruction at 2 weeks

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Radiofrequency Ablation in Treating Patients Who Are... | 临床试验